Cargando…

Efficacy and Safety of Denosumab Therapy for Osteogenesis Imperfecta Patients with Osteoporosis—Case Series

Osteogenesis imperfecta (OI) is a connective tissue disorder that is characterized by low bone density leading to recurrent fractures. The efficacy of the anti-resorption drug denosumab for OI with osteoporosis is still largely unknown. We herein describe the clinical outcomes of eight osteoporotic...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kobayashi, Tsukasa, Nakamura, Yukio, Suzuki, Takako, Yamaguchi, Tomomi, Takeda, Ryojun, Takagi, Masaki, Hasegawa, Tomonobu, Kosho, Tomoki, Kato, Hiroyuki
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2018
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6306860/ https://www.ncbi.nlm.nih.gov/pubmed/30477250 http://dx.doi.org/10.3390/jcm7120479

Ejemplares similares

Efficacy of denosumab therapy for neurofibromatosis type 1 with osteoporosis and history of fractures: a case report
por: Uehara, Masashi, et al.
Publicado: (2018)

Efficacy of denosumab therapy for a 21-year-old woman with Prader-Willi syndrome, osteoporosis and history of fractures: a case report
por: Uehara, Masashi, et al.
Publicado: (2019)

Efficacy of Denosumab for Osteoporosis in Two Patients with Adult-Onset Still’s Disease—Denosumab Efficacy in Osteoporotic Still’s Disease Patients
por: Kumaki, Daiki, et al.
Publicado: (2018)

Efficacy of denosumab in two cases with multiple-system atrophy and osteoporosis
por: Uehara, Masashi, et al.
Publicado: (2018)

Denosumab use in osteogenesis imperfecta: an update on therapeutic approaches
por: Majdoub, Fatma, et al.
Publicado: (2023)

Compliance and discontinuation of denosumab treatment in postmenopausal Japanese women with primary osteoporosis or rheumatoid arthritis and osteoporosis
por: Suzuki, Takako, et al.
Publicado: (2017)

Vitamin D and Calcium Are Required during Denosumab Treatment in Osteoporosis with Rheumatoid Arthritis
por: Nakamura, Yukio, et al.
Publicado: (2017)

Osteogenesis imperfecta IIC caused by a novel heterozygous mutation in the C-propeptide region of COL1A1
por: Takagi, Masaki, et al.
Publicado: (2014)

Effects of denosumab on bone metabolism and bone mineral density with anti-TNF inhibitors, tocilizumab, or abatacept in osteoporosis with rheumatoid arthritis
por: Suzuki, Takako, et al.
Publicado: (2018)

Vitamin D and calcium are required at the time of denosumab administration during osteoporosis treatment
por: Nakamura, Yukio, et al.
Publicado: (2017)

Two years’ experience with denosumab for children with Osteogenesis imperfecta type VI
por: Hoyer-Kuhn, Heike, et al.
Publicado: (2014)

Calcium and vitamin D supplementation with 3-year denosumab treatment is beneficial to enhance bone mineral density in postmenopausal patients with osteoporosis and rheumatoid arthritis
por: Suzuki, Takako, et al.
Publicado: (2018)

Denosumab versus romosozumab for postmenopausal osteoporosis treatment
por: Kobayakawa, Tomonori, et al.
Publicado: (2021)

Safety and efficacy of denosumab in children with osteogenesis imperfecta - a first prospective trial
por: Hoyer-Kuhn, H., et al.
Publicado: (2016)

Hypercalcemia and hypercalciuria during denosumab treatment in children with osteogenesis imperfecta type VI
por: Trejo, Pamela, et al.
Publicado: (2018)

Vitamin D and Calcium Addition during Denosumab Therapy over a Period of Four Years Significantly Improves Lumbar Bone Mineral Density in Japanese Osteoporosis Patients
por: Suzuki, Takako, et al.
Publicado: (2018)

Clinical and molecular features of patients with COL1 ‐related disorders: Implications for the wider spectrum and the risk of vascular complications
por: Takeda, Ryojun, et al.
Publicado: (2022)

Lung Transplantation in a Patient With Osteogenesis Imperfecta and Osteoporosis
por: Fan, Lena, et al.
Publicado: (2021)

Individualized treatment with denosumab in children with osteogenesis imperfecta – follow up of a trial cohort
por: Hoyer-Kuhn, Heike, et al.
Publicado: (2019)

In vivo laser confocal microscopy findings of a cornea with osteogenesis imperfecta
por: Kobayashi, Akira, et al.
Publicado: (2014)

Changes of Bone-Related Minerals during Denosumab Administration in Post-Menopausal Osteoporotic Patients
por: Suzuki, Takako, et al.
Publicado: (2017)

Mechanisms of Bone Fragility: From Osteogenesis Imperfecta to Secondary Osteoporosis
por: El-Gazzar, Ahmed, et al.
Publicado: (2021)

Osteogenesis imperfecta
por: Vitturi, Bruno Kusznir, et al.
Publicado: (2018)

Osteogenesis Imperfecta
por: Sam, Justin Easow, et al.
Publicado: (2017)

A case of transient neonatal diabetes due to a novel mutation in ABCC8
por: Takagi, Masaki, et al.
Publicado: (2016)

An association with hypopituitarism and 9q subtelomere deletion syndrome
por: Higuchi, Shinji, et al.
Publicado: (2018)

Dentinogenesis imperfecta associated with osteogenesis imperfecta
por: Biria, Mina, et al.
Publicado: (2012)

Childhood Osteoporosis and Presentation of Two Cases with Osteogenesis Imperfecta Type V
por: BRATANIC, Nina, et al.
Publicado: (2015)

How frequent is osteogenesis imperfecta in patients with idiopathic osteoporosis?: Case reports
por: Al Kaissi, Ali, et al.
Publicado: (2017)

A Novel Mutation in LEPRE1 That Eliminates Only the KDEL ER- Retrieval Sequence Causes Non-Lethal Osteogenesis Imperfecta
por: Takagi, Masaki, et al.
Publicado: (2012)

Management of Osteogenesis Imperfecta
por: Ralston, Stuart H., et al.
Publicado: (2020)

How frequent is osteogenesis imperfecta in patients with idiopathic osteoporosis?: Case reports: Erratum
Publicado: (2017)

How frequent is osteogenesis imperfecta in patients with idiopathic osteoporosis?: Case reports: Erratum
Publicado: (2017)

Osteoporosis Improved by Romosozumab Therapy in a Patient With Type I Osteogenesis Imperfecta
por: Dattagupta, Antara, et al.
Publicado: (2023)

Serum bone alkaline phosphatase is a useful marker to evaluate lumbar bone mineral density in Japanese postmenopausal osteoporotic women during denosumab treatment
por: Nakamura, Yukio, et al.
Publicado: (2017)

Evaluation of Stomatognathic Problems in Children with Osteogenesis Imperfecta (Osteogenesis Imperfecta − OI) − Preliminary Study
por: Smoląg, Danuta, et al.
Publicado: (2017)

Denosumab significantly improves lumbar spine bone mineral density more in treatment-naïve than in long-term bisphosphonate-treated patients
por: Suzuki, Takako, et al.
Publicado: (2018)

Persistence of Denosumab Therapy among Patients with Osteoporosis
por: Kobayashi, Kazuyoshi, et al.
Publicado: (2020)

Metaphyseal bands in osteogenesis imperfecta
por: Suresh, SS, et al.
Publicado: (2010)

Radiographic features of osteogenesis imperfecta
por: Renaud, Armelle, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_r8v6mncdipmilkj2c0ab0e3ri5